Diversified Healthcare Trust (DHC) Analyst Forecast
Revenue and earnings estimates published by analysts covering Diversified Healthcare Trust (DHC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Diversified Healthcare Trust, analysts forecast revenue rising from $1409.77T in 2023 to $1687.66T in 2028; the average estimate for 2028 earnings per share is $-0.42; with published estimates ranging from $-0.43 to $-0.41; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD millions)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Diversified Healthcare Trust (DHC) forecast — frequently asked questions
What is the analyst price target for Diversified Healthcare Trust?
Analysts covering Diversified Healthcare Trust (DHC) have a consensus price target of $9.25, 3.6% above the current price of $8.93. Published targets range from $8.00 to $10.50. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Diversified Healthcare Trust's earnings?
The average analyst estimate for Diversified Healthcare Trust (DHC) earnings per share in 2028 is -0.42, with individual estimates between -0.43 and -0.41.
How much revenue is Diversified Healthcare Trust expected to make?
Analysts forecast Diversified Healthcare Trust (DHC) revenue of $1687.66T in 2028, based on 3 published estimates.
How many analysts cover DHC?
3 analysts contribute estimates for Diversified Healthcare Trust (DHC). Thin coverage makes an average less reliable.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.